questionsmedicales.fr
Phénomènes génétiques
Régulation de l'expression des gènes
Épigenèse génétique
Empreinte génomique
Empreinte génomique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Practice Patterns, Physicians'
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Empreinte génomique : Questions médicales les plus fréquentes",
"headline": "Empreinte génomique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Empreinte génomique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-14",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Empreinte génomique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Épigenèse génétique",
"url": "https://questionsmedicales.fr/mesh/D044127",
"about": {
"@type": "MedicalCondition",
"name": "Épigenèse génétique",
"code": {
"@type": "MedicalCode",
"code": "D044127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.308.203"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Empreinte génomique",
"alternateName": "Genomic Imprinting",
"code": {
"@type": "MedicalCode",
"code": "D018392",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anne C Ferguson-Smith",
"url": "https://questionsmedicales.fr/author/Anne%20C%20Ferguson-Smith",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, UK."
}
},
{
"@type": "Person",
"name": "Thomas Eggermann",
"url": "https://questionsmedicales.fr/author/Thomas%20Eggermann",
"affiliation": {
"@type": "Organization",
"name": "Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH University Aachen, Pauwelsstr. 3, D-52074 Aachen, Germany."
}
},
{
"@type": "Person",
"name": "Simon Hippenmeyer",
"url": "https://questionsmedicales.fr/author/Simon%20Hippenmeyer",
"affiliation": {
"@type": "Organization",
"name": "Institute of Science and Technology Austria, Am Campus 1, 3400 Klosterneuburg, Austria. Electronic address: simon.hippenmeyer@ist.ac.at."
}
},
{
"@type": "Person",
"name": "Jinsoo Ahn",
"url": "https://questionsmedicales.fr/author/Jinsoo%20Ahn",
"affiliation": {
"@type": "Organization",
"name": "Functional Genomics Laboratory, Department of Animal Sciences, The Ohio State University, Columbus, OH 43210, USA."
}
},
{
"@type": "Person",
"name": "In-Sul Hwang",
"url": "https://questionsmedicales.fr/author/In-Sul%20Hwang",
"affiliation": {
"@type": "Organization",
"name": "Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, Wanju 55365, Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "YELLOW, SERRATED LEAF is essential for cotyledon vein patterning in Arabidopsis.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39226151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/plphys/kiae465"
}
},
{
"@type": "ScholarlyArticle",
"name": "Histopathological Patterns of Lung Cancer in Iran: A Single-Center Study.",
"datePublished": "2024-09-01",
"url": "https://questionsmedicales.fr/article/39465525",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.31133"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Information-Geometric Formulation of Pattern Separation and Evaluation of Existing Indices.",
"datePublished": "2024-08-29",
"url": "https://questionsmedicales.fr/article/39330071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/e26090737"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tailored micromixing in chemically patterned microchannels undergoing electromagnetohydrodynamic flow.",
"datePublished": "2024-08-21",
"url": "https://questionsmedicales.fr/article/39184284",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1063/5.0209606"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patterns and Complications of Congenital Heart Disease in Adolescents and Adults in Ethiopia.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39195161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jcdd11080253"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Régulation de l'expression des gènes",
"item": "https://questionsmedicales.fr/mesh/D005786"
},
{
"@type": "ListItem",
"position": 4,
"name": "Épigenèse génétique",
"item": "https://questionsmedicales.fr/mesh/D044127"
},
{
"@type": "ListItem",
"position": 5,
"name": "Empreinte génomique",
"item": "https://questionsmedicales.fr/mesh/D018392"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Empreinte génomique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Empreinte génomique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Empreinte génomique",
"description": "Comment diagnostiquer une empreinte génomique ?\nQuels tests sont utilisés pour l'empreinte génomique ?\nPeut-on détecter l'empreinte génomique in utero ?\nQuels signes cliniques indiquent une empreinte génomique ?\nL'empreinte génomique est-elle héréditaire ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Empreinte génomique",
"description": "Quels sont les symptômes d'une empreinte génomique ?\nL'empreinte génomique cause-t-elle des maladies ?\nY a-t-il des symptômes spécifiques aux enfants ?\nLes symptômes varient-ils selon le parent affecté ?\nComment l'empreinte génomique affecte-t-elle le développement ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Empreinte génomique",
"description": "Peut-on prévenir les troubles liés à l'empreinte génomique ?\nLe dépistage prénatal aide-t-il à prévenir ces troubles ?\nLes habitudes de vie influencent-elles l'empreinte génomique ?\nLe suivi médical régulier est-il important ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Empreinte génomique",
"description": "Quels traitements existent pour les troubles liés à l'empreinte génomique ?\nPeut-on guérir les maladies liées à l'empreinte génomique ?\nLes thérapies géniques sont-elles une option ?\nComment gérer les symptômes au quotidien ?\nY a-t-il des médicaments spécifiques pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Empreinte génomique",
"description": "Quelles complications peuvent survenir ?\nL'empreinte génomique augmente-t-elle le risque de cancer ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la vie quotidienne ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Empreinte génomique",
"description": "Quels sont les facteurs de risque d'empreinte génomique ?\nL'âge parental influence-t-il le risque ?\nLes facteurs environnementaux sont-ils significatifs ?\nLes maladies génétiques augmentent-elles le risque ?\nLe mode de vie influence-t-il l'empreinte génomique ?",
"url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Practice+Patterns,+Physicians'&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une empreinte génomique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et l'analyse des marqueurs épigénétiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'empreinte génomique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'analyse de méthylation de l'ADN sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter l'empreinte génomique in utero ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests prénataux peuvent identifier des anomalies liées à l'empreinte génomique."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une empreinte génomique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance ou des troubles métaboliques peuvent indiquer ce phénomène."
}
},
{
"@type": "Question",
"name": "L'empreinte génomique est-elle héréditaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être transmise de manière parentale, affectant la descendance."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une empreinte génomique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, incluant des retards de développement et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "L'empreinte génomique cause-t-elle des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est liée à des maladies comme le syndrome de Prader-Willi et d'Angelman."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des troubles de l'alimentation et des problèmes de comportement."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le parent affecté ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon que l'anomalie provient de la mère ou du père."
}
},
{
"@type": "Question",
"name": "Comment l'empreinte génomique affecte-t-elle le développement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut influencer la croissance, le métabolisme et le comportement des individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés à l'empreinte génomique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais le conseil génétique peut aider les familles à risque."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal aide-t-il à prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage prénatal peut identifier des risques d'empreinte génomique."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles l'empreinte génomique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes peuvent influencer l'expression des gènes, mais la recherche est en cours."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical peut aider à détecter précocement des anomalies liées à l'empreinte."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent influencer l'expression des gènes et l'empreinte."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles liés à l'empreinte génomique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont symptomatiques, incluant thérapies comportementales et soutien nutritionnel."
}
},
{
"@type": "Question",
"name": "Peut-on guérir les maladies liées à l'empreinte génomique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de cure, mais des traitements peuvent améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour ces troubles."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes au quotidien ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins, nutritionnistes et psychologues est recommandée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de médicaments spécifiques, mais des traitements peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques, des retards de développement et des problèmes comportementaux."
}
},
{
"@type": "Question",
"name": "L'empreinte génomique augmente-t-elle le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre l'empreinte génomique et un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la vie quotidienne ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent limiter les activités, nécessitant un soutien constant et des adaptations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme peuvent inclure des problèmes de santé chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'empreinte génomique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux et des anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "L'âge parental influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut augmenter le risque d'anomalies liées à l'empreinte."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies génétiques dans la famille peuvent augmenter le risque d'empreinte génomique."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il l'empreinte génomique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes de vie, comme l'alimentation, peuvent influencer l'expression génétique."
}
}
]
}
]
}
Venation develops complex patterns within the leaves of angiosperms, and the mechanism of leaf vein patterning remains poorly understood. Here, we report a spontaneous mutant that exhibits yellow serr...
Lung cancer (LC) is one of the leading causes of cancer-related deaths worldwide. In Iran, it is the second most common cause of cancer-related deaths for men and the third most common for women. This...
Clinicopathological data of 1382 patients with primary LC diagnosed over 11 years (2012‒2023) at the "National Institute of Tuberculosis and Lung Disease" (NRITLD), Tehran, Iran, were retrospectively ...
Adenocarcinoma was the most common type of cancer found in the patients (42.44%). The median age was 59.69 years (mean: 60.41 years) ranging 24-88 years. The mean male-to-female ratio was 3.65. Additi...
Although some of our findings are consistent with those of previous LC studies, there are some discrepancies, especially concerning the smoking status and median age of the Iranian patients. Therefore...
Pattern separation is a computational process by which dissimilar neural patterns are generated from similar input patterns. We present an information-geometric formulation of pattern separation, wher...
The study unveils a simple, non-invasive method to perform micromixing with the help of spatiotemporal variation in the Lorentz force inside a microchannel decorated with chemically heterogeneous wall...
Congenital heart disease (CHD) encompasses morphofunctional anomalies in the heart and circulatory system present at birth, which may not become apparent until later in life. In Ethiopia, there needs ...
A hospital-based cross-sectional study was conducted on 199 patients with CHDs to assess the patterns and complications of defects. Retrospective data were collected from 16,972 patients who had follo...
The most prevalent types of CHDs in our study population were atrial septal defects (ASDs) at 41.2% (82 cases), ventricular septal defects (VSDs) at 26.6% (53 cases), and patent ductus arteriosus (PDA...
This study found a higher prevalence of CHDs in females (77.8%) compared to males, a trend consistent across various atrial and ventricular defect types. Individuals aged 15 to 25 years exhibited the ...
This study aims to explore the treatment pattern of systemic lupus erythematosus (SLE) in Aotearoa/New Zealand....
SLE patients were linked to the pharmaceutical dispensing data. The use of publicly funded anti-malarials, immunomodulators, biologics, glucocorticoids and bisphosphonates were compared by gender, eth...
Of the 2631 SLE patients, 73.8% used hydroxychloroquine, 64.1% used immunomodulators/biologics and 68.0% used 5 mg or more prednisone daily for at least 90 days. Women were more likely to use hydroxyc...
Adherence to hydroxychloroquine in these patients varied and was lower in men and in Māori. Prednisone is commonly prescribed and used long term. Half of those over the age of 40 years old co-administ...
Hearing loss is known to be a serious issue that impedes human communication. The World Health Organization (WHO) estimates that approximately 20 in 100,000 newborns demonstrate congenital hearing imp...
The reduced quality of life and work productivity among hearing-impaired individuals eventually affects societal outcomes and development. Since limited studies address the nature of hearing-impaired ...
The current research focused on assessing hearing function for 1000 individuals over 12 years to define the rate, most prominent configurations, and the most common characteristics of hearing difficul...
The results showed that sixty-three per 1,000 people have hearing loss, most frequently sensorineural hearing loss. The age range of people with hearing loss was 12 to 89 years old, with a median age ...
The rate of hearing loss in Jordan is higher than worldwide prevalence, which was assumed to be due to genetic factors impacting the auditory system. These findings will assist in creating effective h...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI) in infants and young children worldwide. Using routine statutory health insurance claims data including...
The increasing frequency and severity of droughts present a significant risk to vulnerable regions of the globe, potentially leading to substantial human displacement in extreme situations. Drought-in...
Treating Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) is difficult due to high relapse rates and drug resistance. Tumorigenesis is largely dependent on disruption of the cell cy...
This case-control study used samples from 100 leukemia patients (50 with ALL and 50 with AML) at Shariati Hospital in Tehran, Iran, along with 50 healthy individuals. The expression of CDC27 was analy...
This study highlights the potential of CDC27 as an oncogene, as well as a possible prognostic and diagnostic marker in acute leukemias. It suggests that CDC27 could be a valuable biomarker or therapeu...